Brief: Aptose Enters Into License Agreement With CrystalGenomics To Acquire CG-806 Rights In China

CG Invites

14/06/2018 12:12

June 14 (Reuters) - Aptose Biosciences Inc  APS.TO :
    * APTOSE ENTERS INTO LICENSE AGREEMENT WITH CRYSTALGENOMICS
TO
ACQUIRE CG-806 RIGHTS IN CHINA
    * APTOSE BIOSCIENCES INC - APTOSE WILL NOW OWN WORLDWIDE
RIGHTS TO
DEVELOP AND COMMERCIALIZE CG-806
    * APTOSE BIOSCIENCES INC - TOTAL DEAL VALUE FOR CHINA
TERRITORY,
INCLUDING UPFRONT PAYMENT, IS UP TO US $125 MILLION
    * APTOSE BIOSCIENCES  - NEW AGREEMENT EXTENDS LICENSE
AGREEMENT TO
INCLUDE CHINA
    * APTOSE BIOSCIENCES INC - CRYSTALGENOMICS TO RECEIVE
UPFRONT
PAYMENT OF US $3 MILLION UNDER AGREEMENT

Source text for Eikon:  ID:nGNX4pmVZL 
Further company coverage:  APS.TO 

 ((Reuters.Briefs@thomsonreuters.com;))